FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

635611000001102: Persantin 25mg tablets (Boehringer Ingelheim Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16333701000001117 Persantin 25mg tablets (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16333801000001114 Persantin 25mg tablets (Boehringer Ingelheim Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Is a Product containing precisely dipyridamole 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has excipient Beeswax false Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has active ingredient Dipyridamole false Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Is a Persantin true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Dipyridamole true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Persantin 25mg tablets (Boehringer Ingelheim Ltd) 84 tablet 3 x 28 tablets Is pack of False Persantin 25mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier
Persantin 25mg tablets (Boehringer Ingelheim Ltd) 84 tablet 3 x 28 tablets Has AMP True Persantin 25mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start